Anal Cancer 2025 UPDATE
Two Onc Docs
00:00
Managing Persistent vs Progressive Disease After Chemoradiation
The hosts explain evaluation at 8–12 weeks, monitoring up to 24 weeks for regression, and biopsy/restage on progression.
Play episode from 05:57
Transcript
